Eli Lilly: Is Another Monster Quarter Coming

October 30th is the day when Eli Lilly will report its third-quarter results, including sales of its 'superstars' Zepbound ...
Nottinghamshire Live on MSN

World's biggest-ever seizure of fake weight loss jabs made in East Midlands factory

The UK's medicines regulator (MHRA) and Northamptonshire Police raided the site, making what is believed to be the world's ...
The Manila Times

Innovent's Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3

The proportion of participants achieving HbA1c DREAMS-3 is the world's first Phase 3 clinical trial of a GCG/GLP-1 dual receptor agonist to conduct a head-to-head comparison with semaglutide in ...
Investor's Business Daily on MSN

Apple, Google, Meta, Amazon, Microsoft Earnings Due; Fed Rate Cut, Trump-Xi Ahead

The stock market is at record highs heading into peak earnings week, with AppleAAPL, Microsoft, Meta Platforms, Google and ...